Section 122DD(5) in The Drugs and Cosmetics Rules, 1945
(5)In the case of any serious adverse event occurring to the clinical trial subjects during the clinical trial, the Ethics Committee shall analyze and forward its opinion as per procedures specified under APPENDIX XII of Schedule Y.
